Methylphenobarbitalum [Inn-Latin] en es it fr

Methylphenobarbitalum [Inn-Latin] Brand names, Methylphenobarbitalum [Inn-Latin] Analogs

Methylphenobarbitalum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Methylphenobarbitalum [Inn-Latin] Chemical_Formula


Methylphenobarbitalum [Inn-Latin] RX_link

Methylphenobarbitalum [Inn-Latin] fda sheet

Methylphenobarbitalum [Inn-Latin] msds (material safety sheet)

Methylphenobarbitalum [Inn-Latin] Synthesis Reference

No information avaliable

Methylphenobarbitalum [Inn-Latin] Molecular Weight

246.262 g/mol

Methylphenobarbitalum [Inn-Latin] Melting Point

176 oC

Methylphenobarbitalum [Inn-Latin] H2O Solubility

Slightly soluble

Methylphenobarbitalum [Inn-Latin] State


Methylphenobarbitalum [Inn-Latin] LogP


Methylphenobarbitalum [Inn-Latin] Dosage Forms


Methylphenobarbitalum [Inn-Latin] Indication

For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy.

Methylphenobarbitalum [Inn-Latin] Pharmacology

R-mephobarbital, a barbiturate, is used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain. Barbiturates act as nonselective depressants of the central nervous system (CNS), capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma. In sufficiently high therapeutic doses, barbiturates induce anesthesia.

Methylphenobarbitalum [Inn-Latin] Absorption

Approximately 50% of an oral dose of mephobarbital is absorbed from the gastrointestinal tract.

Methylphenobarbitalum [Inn-Latin] side effects and Toxicity

No information avaliable

Methylphenobarbitalum [Inn-Latin] Patient Information

No information avaliable

Methylphenobarbitalum [Inn-Latin] Organisms Affected

Humans and other mammals